Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


Labcyte is a global biotechnology tools company headquartered in San Jose, California, that develops tools for liquid handling.

The liquid handling systems Labcyte develops use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used in pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Labcyte has 62 U.S. patents and others internationally.

Echo Acoustic Liquid Handlers are able to dispense in 2.5 or 25 nanoliter increments from source plates, upwards, onto inverted destination plates, where they are suspended with surface tension.

Acoustic droplet ejection (ADE) technology uses the gentle energy of sound waves to move liquids at nanoliter resolution. The technology does not contact the liquid in any way, avoiding the risk for sample loss, carryover or cross-contamination, and enables miniaturization with fluid transfers at volumes as low as 2.5 nanoliters.

Labcyte has integrated its acoustic liquid handling technology with mass spectrometry in a process referred to as Acoustic-MS. Acoustic-MS has been shown to deliver high-quality data at extremely low volumes. As part of the agreement, prototype systems will be installed at select Merck sites where they will be evaluated within the context of existing and future workflows.

Labcyte is one of the founding members of the Genome Project-write (GP-write) Industry Advisory Board, which is charged with developing complete workflow solutions for laboratories participating in the project. The company has an agreement with the Center of Excellence for Engineering Biology (CEEB), which oversees GP-write. The agreement includes providing preferred pricing and support to researchers at qualified laboratories affiliated with and contributing to the GP-write mission and goals. Labcyte will also provide selected researchers with early access to certain newly developed products.


April 17, 2018
Labcyte/ Merck partnership announced

Labcyte announced that the company has entered an agreement with Merck to utilize Acoustic-Mass Spectrometry in drug discovery and development.

January 2017
Labcyte raises a $5,000,000 venture round.
May 2015
Labcyte raises a $17,000,000 venture round from Oxford Finance Llc and Silicon Valley Bank.
January 8, 2013
Labcyte raises a $5,300,000 series D round from Abingworth, Alloy Ventures, Delphi Ventures and GE Ventures.
January 2013
Labcyte raises a $5,300,000 series D round from Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, GE Ventures and H&Q Healthcare Investors.
November 2011
Labcyte raises a $196,000 grant.
March 2008
Labcyte raises a $3,800,000 series C round from Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures and Sprout Group.
July 2005
Labcyte raises a $21,000,000 series C round from Abingworth and Cross Atlantic Capital Partners.
Labcyte was founded by Richard Ellson.
July 2002
Labcyte raises a $22,000,000 series B round from Abingworth, Alloy Ventures, Delphi Ventures, Palo Alto Investors and Sprout Group.

Funding Rounds



Further Resources



Golden logo
By using this site, you agree to our Terms & Conditions.